Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis: introduction to novel approaches to the treatment of sodium retention.
Moreau
R
R
Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire, INSERM, Hôpital Beaujon, Clichy, France.
Lebrec
D
D
D018674:Adrenergic Antagonists / Q000627:therapeutic use; D000804:Angiotensin II / Q000502:physiology*; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use; D006801:Humans; D007687:Kidney Tubules, Proximal / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000503:physiopathology*; D019808:Losartan / Q000627:therapeutic use; D008954:Models, Biological; D009318:Natriuresis / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000502:physiology*; D015398:Signal Transduction; D012964:Sodium / Q000378:metabolism*; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D018674:Adrenergic Antagonists; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D017923:Sodium-Hydrogen Exchangers; D000804:Angiotensin II; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D019808:Losartan; D009638:Norepinephrine